Guest Editorial

//Guest Editorial

Acquisitions in the Life Sciences Start-Up Space: A Principal-Agent Problem in the Making

By | October 31st, 2017|Blog, Guest Editorial|

Acquisitions in the Life Sciences Start-Up Space: A Principal-Agent Problem [...]

Progress Report: Canada’s Gilead of the North

By | October 25th, 2017|Blog, Guest Editorial|

Progress Report: Canada’s Gilead of the North By Roberto Bellini [...]

Digital Innovation in Canada

By | September 21st, 2017|Blog, Guest Editorial|

Digital Innovation in Canada Are you prepared to capitalize on [...]

Jason Donville at the Bloom Burton & Co. Healthcare Investor Conference

By | May 6th, 2016|Blog, Commentary, Guest Editorial|

The Donville Kent (DKAM) investment team recently attended the Bloom [...]

Guest Editorial- Keeping your business investor friendly

By | February 25th, 2016|Blog, Commentary, Guest Editorial|

If someone asks you how your business is doing, you [...]

Guest Editorial

By | November 22nd, 2015|Blog, Commentary, Guest Editorial|

Canada continues to be one of the world’s leaders in [...]

Cross-Border Mergers and Acquisitions – 5 Tips for a Successful Deal

By | August 31st, 2015|Blog, Commentary, Guest Editorial|

As the world becomes one giant global marketplace, it is [...]

Focusing on Fundamentals in a Hot Biotech Market: How Management and Bankers Can Help

By | March 9th, 2015|Blog, Commentary, Guest Editorial|

I appreciate the chance to contribute to Brian and Jolyon’s [...]

Canada Will Have a Gilead of the North Within 10 Years

By | February 9th, 2015|Blog, Commentary, Guest Editorial|

  Many in our industry remember the golden era during [...]

The Tragedy in the Commercialization of Canadian Life Sciences Discoveries

By | January 19th, 2015|Blog, Commentary, Guest Editorial|

  “Australia excels in biomedical research but sucks at commercialisation.” [...]